Women Learned the Truth from the Media, not Cancer "Charities"
Nevertheless, women only learned of the breast cancer risk associated with the use of HRT accidentally when a story broke in the national news in 2002 that the Women’s Health Initiative study had been stopped prematurely because the study subjects using HRT were dying of heart attacks and strokes.
That’s when journalists learned about a 26% increased risk of invasive breast cancer associated with use of HRT. Cancer “charities” weren’t the first to reveal that simple, but deadly, a fact that scientists had known for years.
Nearly one-half of the HRT consumers in the U.S. stopped using hormones prescribed for menopause symptoms and breast cancer incidence declined markedly within a year. Scientists reported a 7% decline in breast cancer rates for 2003.
Once HRT use “fell,” it should have been obvious that contraceptive pills would fall as well: both include the same type of drugs, but the contraceptive pill delivers an even higher dose. Cancer “charities” were then forced to acknowledge the pill as a risk factor on their websites, but the information was quietyly buried on their sites without the same fanfare associated with the news about HRT. And they downplayed the risk.
Karen Malecis Founder and President of the Coalition on Abortion/Breast Cancer.
1. “Susan G. Komen’s moral dilemma,” by Judy Roberts, National Catholic Reporter, October 5, 2014.
2. “Did Komen reverse its position to stop funding Planned Parenthood?” by Karen Malec, newsletter, Coalition on Abortion/Breast Cancer. February 3, 2012.
3. Fasal E, Paffenbarger RS Jr. Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst 1975;55(4):767-773.
4. Lees AW, Burns PE, Grace M. Oral contraceptives and breast disease in premenopausal Northern Albertan women. Int J Cancer 1978;22(6):700-707.
5. Shipman JJ. Oral contraceptives and breast cancer. Br Med J 1964;2(5409):629.
6. Stoll BA, Oral contraceptives and breast cancer. Br Med J 1964;2(5413):875.
7. Hunt K, Vessey M, McPherson K, Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 1987;94(7):620-635.
8. Mills PK, Beeson WL, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer 1989;64(3):591597.
9. Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24(1):29-43.
10. Writing group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal Results from the Women’s Health Initiative Randomized Controlled Trial. JAMA 2002;288(3):321333.
11. Schneider AP, Zainer CM, Kubat CK, Mullen NK, Windisch AK. The breast cancer epidemic: 10 facts. The Linacre Quarterly 2014;81(3):244-277.
The Coalition on Abortion/Breast Cancer, at http://www.abortionbreastcancer.com/, is an international women’s organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.